18.7 C
New York
Thursday, June 4, 2026

Tag: increase

LRE Advisors Launches First Laundromat Advisory and Market Intelligence Firm in $7 billion U.S. Industry

Proprietary AI-powered market intelligence and specialized advisory services mark a structural shift in how laundromat operators and institutional investors find and launch new laundromats.NEW...

X-energy Reports First Quarter 2026 Results

X-energy Reports First Quarter 2026 Results

Sister villages embrace for poverty fight

Chinese model targets local issues, improves livelihoods in remote Laos settlementLUANG PRABANG, Laos, June 4, 2026 /PRNewswire/ -- A report from Chinadaily.com.cnTo mark the...

Press Release: Sanofi launches 2026 global employee stock purchase plan

Sanofi launches 2026 global employee stock purchase plan

Teacher confidence in AI grows, but call for more training to prepare students

LONDON, June 4, 2026 /PRNewswire/ -- New research from Pearson (FTSE: PSON.L), the world's lifelong learning company, suggests that UK teachers' confidence in using AI...

Veeva Summit Previews Falcon and the Path to Agentic Biopharma

More than 2,000 gathered to see the future of industry AI AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi, and Sobi...

match.asia Launches Exit HealthCheck to Help SMEs Avoid Common M&A Deal Killers

Free exit readiness service helps business owners identify problem areas before entering the M&A market.
Free exit readiness service helps business owners identify problem areas before entering the M&A market.

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

LONGi Showcases LONGi ONE at SNEC 2026, Advancing Native Solar-Plus-Storage Integration

SHANGHAI, June 4, 2026 /PRNewswire/ -- At SNEC 2026, LONGi further advanced its LONGi ONE solar-plus-storage strategy, demonstrating how a unified technology architecture can address long-standing...

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

LGI Homes, Inc. Reports May 2026 Home Closings

THE WOODLANDS, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 498 homes in May 2026, which includes the closing of 24 currently or previously leased single-family rental homes. This represents a 19.7% increase compared to 416 homes closed in May 2025.

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity

PHX Energy Announces Increase to its 2026 Capital Expenditure Program

CALGARY, Alberta, June 03, 2026 (GLOBE NEWSWIRE) -- PHX Energy" or the "Corporation") (TSX: PHX) announces that its Board of Directors (the "Board") has approved an increase to its 2026 capital expenditure program (the "Program") to $80 million, a $15 million increase from the previously announced Program.

Diversified Royalty Corp. Announces June 2026 Cash Dividend

VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of June 1, 2026 to June 30, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on June 30, 2026 to shareholders of record as of the close of business on June 15, 2026.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsIncrease